For general wellness or anti-aging purposes, providers often start with relatively low doses and adjust based on patient response
Explored as a possible aid for recovery and lean-mass preservation in frail or catabolic populations, though a Merck-sponsored Phase 2b trial in elderly hip-fracture patients (Adunsky et al., 2011, Archives of Gerontology and Geriatrics, PMID 21067829) was halted early over a cardiac safety signal rather than demonstrating a clear functional benefit
In another set of experiments, cells were preincubated with 10 M LY294002 for 30 min at 37 C and then stimulated with bTNF- for 5 min
Skin rejuvenation cycles are typically 8 to 12 weeks
Search Strategy A comprehensive search of PubMed/MEDLINE and the Cochrane Central Register of Controlled Trials (CENTRAL) was performed from database inception through the final search date
Unique features - Vitamin B12 megadose injection, 2500 micrograms, provides extended effects without compromising safety